News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Medtronic and Intuitive Surgical, two leading medical device companies, have faced challenges this year but are poised for a rebound. Medtronic offers a strong dividend yield and diversified product portfolio, while Intuitive Surgical leads the robotic-assisted surgery market with its innovative da Vinci system. …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%This article provides an analysis and forecast for Medtronic PLC (MDT) stock. It includes recent stock performance data, key financial metrics, and mentions two in-depth analyses published by TradingKey. These analyses cover broader market trends and Medtronic's strategy for capitalizing on the aging global …
Gradient Investments LLC increased its stake in Medtronic PLC (NYSE:MDT) by 3.9% during the second quarter, bringing its total holdings to 496,513 shares valued at approximately $38.8 million. Other institutional investors also adjusted their positions in the medical technology company, with 82.06% of the …
The Czech National Bank increased its stake in Medtronic PLC (NYSE:MDT) by 4.7% in the second quarter, purchasing an additional 16,292 shares, bringing its total holdings to 365,443 shares valued at approximately $28.6 million. Medtronic recently exceeded quarterly earnings expectations, reporting $1.55 in adjusted …
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic has received an expanded CE mark for its Affera mapping and ablation system and Sphere-9 catheter to treat ventricular arrhythmias, including ventricular tachycardia. The Sphere-9 catheter also recently received breakthrough device designation from the FDA, acknowledging the need for more effective treatments for …
Palouse Capital Management Inc. significantly increased its stake in Medtronic PLC (NYSE:MDT) during the second quarter, acquiring an additional 29,275 shares to bring its total holdings to 57,027 shares valued at approximately $4.46 million. This move comes as Medtronic exceeded analyst expectations with its …
180 Wealth Advisors LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 75% in the second quarter, selling 29,822 shares and retaining 9,951 shares valued at $778,000. Despite this reduction, Medtronic reported strong quarterly results with revenue of $9.81 billion and adjusted EPS …
Balefire LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 67.1% in the second quarter, selling 25,744 shares but still retaining 12,614 shares valued at $987,000. Despite this institutional sell-off and recent price target reductions by analysts, Medtronic holds a "Moderate Buy" consensus …
Medtronic's Sphere-9 catheter and Affera mapping and ablation system has secured a CE mark in Europe for ventricular arrhythmia treatment, making it the first all-in-one dual-energy catheter CE marked for this indication. The company is also pursuing US FDA clearance for the system for …
(RTTNews) - Thursday, Medtronic plc (MDT) announced the expansion of the CE Mark indication for the Affera Mapping and Ablation System with Sphere-9 Catheter to treat ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes. The company stated that the expansion reflects its efforts …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic (NYSE: MDT) has announced an expanded CE Mark indication for its Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). The Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, …
Medtronic has received an expanded CE Mark indication for its Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). This makes the Sphere-9 catheter the first all-in-one mapping and ablation, large-tip focal, …
Canandaigua National Bank & Trust Co. has acquired a new stake of 11,842 shares in Medtronic PLC (NYSE:MDT) during the second quarter, valued at approximately $926,000. Medtronic exceeded quarterly expectations with $1.55 EPS and $9.81 billion in revenue, and raised its quarterly dividend to …
Medtronic is advancing AI-assisted surgery with its new Touch Surgery Aide platform and the Hugo robotic surgery system. The platform, which has received FDA clearance for its first AI algorithm (Instrument Exit Point or IEP), aims to improve surgical safety, quality, and efficiency by …
Key Points Medtronic’s stock has slumped over the past five years. But its restructuring efforts could bring back the bulls.10 stocks we like better than Medtronic › Shares of Medtronic(NYSE: MDT), one of the world's largest medical device makers, have declined by more than …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic's EVP & President of Neuroscience, Thompson Kweli, received equity compensation including 17,306 performance share units, 49,167 stock options with a strike price of $86.68, and 6,923 restricted stock units. Additionally, 1,739 shares were withheld for tax purposes related to previously vested RSUs. The …
Medtronic plc's SVP, Chief HR Officer Walter Matthew R. received significant equity awards on August 3, 2026, including 5,769 restricted stock units, 14,421 performance share units, and stock options for 40,973 ordinary shares. The performance share units can yield between 0 and 34,610 shares …
Medtronic plc's EVP Michael Marinaro received a significant equity award package, including restricted stock units (RSUs) with multi-year vesting, performance share units (PSUs) with a potential payout up to 65,760 shares, and stock options exercisable at $86.68 per share. Additionally, 3,356 ordinary shares were …
A federal jury in Boston has ordered Medtronic's Covidien unit to pay an Alabama man and his wife $88 million. This verdict marks the first trial out of thousands of lawsuits claiming injuries from Covidien's hernia-repair mesh implants. The jury found that Medtronic failed …
Medtronic Plc HQ-by JHVEPhoto via iStock Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients. Valued at $109.3 billion by market cap, the company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Learn the warning signs of stroke and how new technologies are transforming neurovascular care. NORTHAMPTON, MA / ACCESS Newswire / August 4, 2026 / Medtronic - Your brain controls everything from how you move and speak to how you think, remember, and experience the …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic plc (MDT) shows a promising 15% upside potential, with analysts setting an average price target of $98.44. The company, a global leader in medical devices, boasts robust revenue growth of 9.90%, a healthy return on equity of 9.84%, and a substantial free cash …
ENAD, Korea's First and Only AI-Assisted Solution Approved for Both Upper and Lower GI Endoscopy ENAD Secures Singapore Hospital Adoption in Competition with Medtronic, Olympus, and Fujifilm Rapid Market Breakthrough Follows Singapore HSA Approval; Joint Research to Drive Further AI Performance Gains SEOUL, South …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic (MDT) closed at $86.68 in the latest trading session, marking a +1.51% move from the prior day. The stock outpaced the S&P 500's daily gain of 1.48%. Elsewhere, the Dow gained 1.32%, while the tech-heavy Nasdaq added 2.13%. The medical device company's shares …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS reaching $2.80, exceeding expectations by $0.30. However, the stock declined as investors focused on concerns …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%In late July 2026, Medtronic voluntarily initiated a Class II recall of specific lots of its DLP One-Piece Pediatric Arterial Cannula after two complaints revealed loose foreign material with trace blood, affecting worldwide distribution including several U.S. states. Around the same time, Medtronic led …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Shares of Medtronic PLC (MDT) declined by 2.09% to $85.71, ending a five-day winning streak despite a generally strong day for the stock market. The S&P 500 Index rose by 1.66%, and the Dow Jones Industrial Average increased by 1.19%. This performance indicates that …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic has invested $37 million in CoreMap to accelerate the development of its atrial fibrillation mapping platform. This Series C funding round aims to bring CoreMap's technology, which identifies cardiac sites driving complex arrhythmias for improved ablation treatment, to market faster. The investment highlights …
Medtronic (MDT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this medical device company have returned +10.5% over …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%CoreMap has secured $37 million in a Series C financing round, led by Medtronic, to advance its electrophysiology mapping system. This funding will accelerate the development of CoreMap's next-generation platform for treating and diagnosing atrial fibrillation (AF) by providing more precise, data-driven insights to …
Michelle Quinn, EVP, GC and Secretary of Medtronic plc, reported a tax-withholding transaction where 2,069 Ordinary Shares were withheld upon the vesting of restricted stock units. Following this, she directly holds 20,375 Ordinary Shares, which includes 697 shares acquired through dividend reinvestment. This Form …
Key Points Medtronic underperformed the market over the past five years. But it’s still a compelling turnaround play for value-oriented income investors.10 stocks we like better than Medtronic › Medtronic(NYSE: MDT), one of the world's largest medical device makers, was once a reliable blue …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%This article provides a revenue breakdown for Medtronic PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (MDTC34) based on data from TradingView. It highlights that the "Rest of World" segment contributed the most to revenue, with BRL 97.70 billion last year. The content …
Search by ticker symbol or company name and select a result to open its chart.